February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
November 1, 2019 | Press Releases Validant Acquires DataRevive, a Regulatory Strategy and Consulting Business Focused on Novel Therapeutics and Biologics Carla Nieser 2 Minute Read